HanAll Biopharma Co., Ltd. mutengo wemakesi

HanAll Biopharma Co., Ltd. capitalization

Mazuva ano misika yemakemikari ye HanAll Biopharma Co., Ltd. is 1 143 068 557 312 South Korean Won.

+116 587 954 176 ₩ (+11.36%)

shanduko ye capitalization kubva zuro

Webhusaiti yedu inotora ruzivo rwe HanAll Biopharma Co., Ltd. capitalization yanhasi kubva kune yakavhurika masosi. Zvichienderana nekutengeserana kwe stock quote HanAll Biopharma Co., Ltd. pamusika wekutengesa masheya, unogona kuongorora capitalization ye HanAll Biopharma Co., Ltd.. HanAll Biopharma Co., Ltd. capitalization yanhasi pawebsite yedu yekureva. HanAll Biopharma Co., Ltd. cap yemusika yakawedzera ne $ 116 587 954 176.

HanAll Biopharma Co., Ltd. ivhu rekutengeserana

Nhasi kutengeswa kwezvikamu zve HanAll Biopharma Co., Ltd. zvakave 807 576 South Korean Won.

+701 053 ₩ (+658.12%)

kuchinja kwehuwandu hwebhizimisi kubvira zuro

HanAll Biopharma Co., Ltd. yekutengeserana yakawanda nhasi = 807 576 US madhora. Nhasi, HanAll Biopharma Co., Ltd. kutengesa kwakaitika pamisika yakawanda yemasheya. HanAll Biopharma Co., Ltd. chati yekutengesa iri pane yedu webhusaiti zuva rega rega. HanAll Biopharma Co., Ltd. capitalization yakawedzera kana ichienzaniswa nezuro.

Ratidza: HanAll Biopharma Co., Ltd. (009420.KS) Kuti South Korean Won (KRW)

HanAll Biopharma Co., Ltd. musika wekodhi chati

HanAll Biopharma Co., Ltd. capitalization yemusika pagirazi nemakore. Shanduko in HanAll Biopharma Co., Ltd. capitalization pamwedzi ndeye 0%. 0% pagore - shanduko mumusika capitalization ye HanAll Biopharma Co., Ltd.. Iyo capitalization yemusika we HanAll Biopharma Co., Ltd. ikozvino yakaenzana ne 1 143 068 557 312 US madhora.

Vhiki

Mwedzi

3 months

Gore

3 years

HanAll Biopharma Co., Ltd. capital capital history

Zuva	Capitalization Capitalization (mutengo capital) ndiyo kukosha kwemusika wezvikamu zvose zvekambani zvakatengeswa pamutengo wekutengesa. Market capitalization yakaenzana nemutengo wezvikamu zvinowanikwa nenhamba yezvikamu zvakakosha.
04/05/2023	1 143 068 557 312 ₩
03/05/2023	1 026 480 603 136 ₩
02/05/2023	1 029 015 142 400 ₩
28/04/2023	1 039 153 168 384 ₩
27/04/2023	1 036 618 694 656 ₩
26/04/2023	1 059 429 351 424 ₩
25/04/2023	1 051 825 799 168 ₩

HanAll Biopharma Co., Ltd. vhidhiyo chati

Vhiki

Mwedzi

3 months

Gore

3 years

HanAll Biopharma Co., Ltd. nhoroondo yemota data

Zuva	Bhuku (24h) Nhamba yekutengeserana yeHanAll Biopharma Co., Ltd. zvikamu ndeyewandu hwezvinhu zvose zvekutengeserana ne009420.KS zvikamu zvakatengwa uye zvinotengeswa panguva yakasarudzwa.
04/05/2023	807 576 ₩
03/05/2023	106 523 ₩
02/05/2023	236 216 ₩
28/04/2023	153 053 ₩
27/04/2023	621 834 ₩
26/04/2023	189 859 ₩
25/04/2023	307 696 ₩

HanAll Biopharma Co., Ltd. musika capitalization uri $ 1 143 068 557 312 at 04/05/2023. HanAll Biopharma Co., Ltd. capitalization pa 03/05/2023 zvakaenzana 1 026 480 603 136 US madhora. 02/05/2023 HanAll Biopharma Co., Ltd. musika capitalization yakaenzana 1 029 015 142 400 US madhora. HanAll Biopharma Co., Ltd. capitalization yakakura kusvika 1 039 153 168 384 US madhora ku 28/04/2023.

Musika capitalization ye HanAll Biopharma Co., Ltd. yakanzi 1 036 618 694 656 US madhora pa 27/04/2023. 26/04/2023 HanAll Biopharma Co., Ltd. capitalization yakaenzana 1 059 429 351 424 US madhora. Musika capitalization ye HanAll Biopharma Co., Ltd. yakanzi 1 051 825 799 168 US madhora pa 25/04/2023.

Iko mari yepamusoro yeHanAll Biopharma Co., Ltd. nhasi ndeye 1 143 068 557 312 ₩. Imari yepamusi yeHanAll Biopharma Co., Ltd. yakachinja +11.36% inofananidzwa nezuro. Nhamba yekutengeserana ye 009420.KS nhengo dze HanAll Biopharma Co., Ltd. musi wekupedzisira wekutengesa yakava 807 576 ₩. Kutengeswa kwezvikamu zve HanAll Biopharma Co., Ltd. zvakachinjwa kusvika +658.12% zvichienzaniswa nezuva rekutanga rebhizimisi.